Harbor Clinical

Women-Owned Wednesday! This post pays tribute to Alma Levant Hayden, an American chemist and one of the first African American women to gain a scientist position at a scientific agency in Washington D.C. Hayden served at various agencies during her illustrious career, including the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Her research was instrumental in identifying the ingredients in Krebiozen, a controversial and expensive alternative cancer treatment. Although Hayden passed away in 1967, her legacy lives on to this day. Source: https://hubs.li/Q02Czh7f0 #womenownedwednesday #WOW #FDA #NIH #womeninscience #STEM #womeninSTEM #krebiozen #cancerresearch #almalevanthayden

The first day of CTO 2024 is off to a great start! Swing by and see Chris Conner and Ann Conner at booth 29. #CTOEastcoast #ClinicalTrials #Oncology #healthcare #pharma

More than 500,000 American men undergo vasectomies each year. The procedure has remained basically the same for the last 40 years, but that could change soon, thanks to a new medical device developed by Signati. Called the Separo, the device cuts and seals each part of the vas deferens (the tubes that carry sperm) in just 4 seconds. The tool aims to reduce procedure time and offer a minimally invasive treatment approach. Currently, Signati is enrolling patients in a clinical trial. Source: https://hubs.li/Q02Czb3q0 #clinicaltrials #medicaldevices #signati #separo #vasectomies #menshealth #urology #signatimedical #minimallyinvasivesurgery

Our team is gearing up for Clinical Trials in Oncology East Coast 2024! We hope to see you there, please find us at booth 29. #CTOEastcoast #ClinicalTrials #Oncology #healthcare #pharma

Clarkson Consulting recently released the results of its third annual CIO survey and it provides invaluable insights into the current relationship between IT and other departments, the enterprise resources companies are investing in, and the most valuable attributes when selecting outsourcing or managed services partners. Click the provided link to learn more, but here’s a spoiler: In 2024 budgeting is more important than ever and AI is on the rise. Source: https://hubs.li/Q02Cz4Hl0 #CIO #lifesciencescompanies #budgeting #AI #clarksonconsulting #cheifinformationofficer #strategicplanning #organizationalresiliance #ITbudgetallocation #ethicalAIusage

Traumatic brain injuries (TBIs) are a leading cause of disability in the U.S., and a growing body of evidence suggests they may increase the risk of Alzheimer’s disease and dementia. For years, scientists have wondered if there was a way to slow down post-TBI neurodegeneration and now they may have an answer. Researchers at the University of Southern California (USC) have discovered that inhibiting a gene called KCNJ2 in a mouse model seems to protect brain cells from TBI-related changes. Specifically, it prevents the death of nerve cells, reducing the risk of long-term brain damage. Although these findings are from an animal study, scientists hope the same results will translate to humans. Source: https://hubs.li/Q02CnSYt0 #traumaticbraininjury #TBI #USC #mousestudies #geneinhibition #neurodegenerativediseases #dementia #Alzheimersdisease

Women-Owned Wednesday! In today’s WOW installment, we’re paying tribute to Evelyn Nicol, an American immunologist and microbiologist best known for isolating the herpes zoster virus. Nicol was also one of the first African American women to receive a patent in molecular biology. Nicol retired in 1990 but spent the last 30 years of her life advocating for black biologists and microbiologists. Outside the lab, she was very active and enjoyed various hobbies, including oil painting, tennis, and bridge. Source: https://hubs.li/Q02CzgKf0 #womenownedwednesday #WOW #immunology #microbiology #womeninSTEM #molecularbiology #womenshistory #STEM

Serving in any type of leadership capacity requires grit and determination. It’s no wonder then that executives and other C-suite members are always looking for advice on how to succeed during tough times. One resource you might not have considered: The U.S. Army War College’s VUCA framework.VUCA describes how successful leaders navigate volatility, uncertainty, complexity, and ambiguity. It’s also an excellent foundation for positive business outcomes. This article from Harvard Business Review explains why. (Be sure to save this post for later; there’s lots of great advice.) Source: https://hubs.li/Q02CnYcY0 #leadershiptips #VUCAframework #beabetterleader #csuite #decisionmaking #activelistening #businessoptimization #professionalgrowth #leadership

Johnson & Johnson is teaming up with rare disease biotech, Rallybio, to support research into fetal and neonatal alloimmune thrombocytopenia (FNAIT), a rare blood disorder. Under the deal, Rallybio will receive an upfront $500,000 payment from J&J to raise awareness about the pharma's FNAIT therapy program as the biotech conducts a natural history study for RLYB212, a human monoclonal anti-HPA-1a antibody. Source: https://hubs.li/Q02CnLQp0 #Johnson&Johnson #biotech #Rallybio #rarediseases #FNAIT #womenshealth #CRO #deals

On July 9th and 10th I will be attending the Clinical Trials in Oncology conference in Burlington, MA! I hope to see some of my network there, please swing by booth number 29 or book a meeting with me https://lnkd.in/ekWFZwVi.